Low-protein diet applied as part of combination therapy or stand-alone normalizes lifespan and tumor proliferation in a model of intestinal cancer
Tumors of the intestinal tract are among the most common tumor diseases in humans, but, like many other tumor entities, show an unsatisfactory prognosis with a need for effective therapies. To test whether nutritional interventions and a combination with a targeted therapy can effectively cure these cancers, we used the fruit fly Drosophila as a model. In this system, we induced tumors by EGFR overexpression in intestinal stem cells. Limiting the amount of protein in the diet restored life span to that of control animals. In combination with a specific EGFR inhibitor, all major tumor-associated phenotypes could be rescued. This form of treatment was also successful in a real treatment scenario, which means when they started after the full tumor phenotype was expressed. In conclusion, reduced protein administration can be a very promising form of adjuvant cancer therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Aging - 13(2021), 21 vom: 12. Nov., Seite 24017-24036 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Proske, Alina [VerfasserIn] |
---|
Links: |
---|
Themen: |
Afatinib |
---|
Anmerkungen: |
Date Completed 01.02.2022 Date Revised 01.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.18632/aging.203692 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333047990 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333047990 | ||
003 | DE-627 | ||
005 | 20231225220832.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.18632/aging.203692 |2 doi | |
028 | 5 | 2 | |a pubmed24n1110.xml |
035 | |a (DE-627)NLM333047990 | ||
035 | |a (NLM)34766923 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Proske, Alina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Low-protein diet applied as part of combination therapy or stand-alone normalizes lifespan and tumor proliferation in a model of intestinal cancer |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.02.2022 | ||
500 | |a Date Revised 01.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Tumors of the intestinal tract are among the most common tumor diseases in humans, but, like many other tumor entities, show an unsatisfactory prognosis with a need for effective therapies. To test whether nutritional interventions and a combination with a targeted therapy can effectively cure these cancers, we used the fruit fly Drosophila as a model. In this system, we induced tumors by EGFR overexpression in intestinal stem cells. Limiting the amount of protein in the diet restored life span to that of control animals. In combination with a specific EGFR inhibitor, all major tumor-associated phenotypes could be rescued. This form of treatment was also successful in a real treatment scenario, which means when they started after the full tumor phenotype was expressed. In conclusion, reduced protein administration can be a very promising form of adjuvant cancer therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Drosophila | |
650 | 4 | |a EGFR | |
650 | 4 | |a afatinib | |
650 | 4 | |a cancer | |
650 | 4 | |a dietary protein restriction | |
650 | 4 | |a stem cells | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
700 | 1 | |a Bossen, Judith |e verfasserin |4 aut | |
700 | 1 | |a von Frieling, Jakob |e verfasserin |4 aut | |
700 | 1 | |a Roeder, Thomas |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Aging |d 2008 |g 13(2021), 21 vom: 12. Nov., Seite 24017-24036 |w (DE-627)NLM192249398 |x 1945-4589 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2021 |g number:21 |g day:12 |g month:11 |g pages:24017-24036 |
856 | 4 | 0 | |u http://dx.doi.org/10.18632/aging.203692 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2021 |e 21 |b 12 |c 11 |h 24017-24036 |